PET imaging of TIGIT expression on tumor-infiltrating lymphocytes.

CONCLUSIONS: This study develops and validates novel TIGIT-specific 64Cu and 89Zr PET probes for quantifying TIGIT expression on TILs for diagnosis of patient selection for anti-TIGIT therapies. PMID: 33408249 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33408249?dopt=Abstract

Source: Clinical Cancer Research - January 6, 2021 Category: Cancer & Oncology Authors: Shaffer T, Natarajan A, Gambhir SS Tags: Clin Cancer Res Source Type: research